The Insight Partners Latest Research for Report “Antifungal Drugs Market Forecast to 2028″ Focuses Global Analysis by Infection Type (Superficial Fungal Infection and Systemic Fungal Infection), Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, and Others), Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, and Others), and Dosage Form (Drugs, Ointment, Powder, and Others)
“Antifungal Drugs Market Forecast to 2028 – Global Analysis – by Infection Type, Drug Type, Therapeutic Indication, and Dosage Form,” the market is expected to grow from US$ 11,135.3 million in 2021 to US$ 13,997.4 million in 2028; it is expected to grow at a 3.3% from 2022 to 2028.
Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00003745/
The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the antifungal drugs market is primarily attributed to rising prevalence of fungal infections; increasing incidences of cancers, HIV, and hospital-acquired infections; and favorable government initiatives to combat the antifungal diseases. However, a lack of awareness regarding fungal infections is hampering the market growth.
Report Segmentations:
Based on infection type, the antifungal drugs market is divided into superficial fungal infection and systemic antifungal infection. Based on drug type, the global antifungal drugs market is segmented into echinocandis, azoles, polyenes, allylamines, and others. In 2021, the azoles segment held the largest share of the market. However, the polyenes segment is expected to grow at the fastest rate during the forecast period. Azole antifungals are a group of medicines that contain an azole ring and prevent the growth of a wide range of fungi. Azole antifungal agents can be used to treat fungal infections of the body and skin, including athlete’s foot, nail infections, ringworm, and vaginal candidiasis. Based on the dosage form, the market is segmented into drugs, ointment, powder, and others. Based on therapeutic indication, the market is segmented into aspergillosis, dermatophytosis, candidiasis, and others.
Based on drug type, the global antifungal drugs market is segmented into echinocandis, azoles, polyenes, allylamines, and others. In 2021, the azoles segment held the largest share of the market. However, the polyenes segment is expected to grow at the fastest rate during the forecast period.
Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003745/
Based on region, the global antifungal drugs market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The US is the largest market in North America. Asia Pacific is expected to exhibit the fastest growth due to growing healthcare infrastructure and evolving pharmaceutical & biopharmaceutical industries. Further, India is expected to grow at the highest CAGR in the Asia Pacific antifungal drugs market during the forecast period. The study conducted in 2015 by the Postgraduate Institute of Medical Education and Research (PGIMER) stated that 7 out of per 1,000 patient is affected with fungal infection. Also, the country has the presence of various pharmaceutical companies working on generic and innovative drug formulations. In addition, the pharmaceutical industry in the country is growing rapidly, which is expected to propel the market growth during the forecast period.
Company Profiles:
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Merck And Co., Inc.
- Scynexis Inc.
- Novartis International AG
- Abbott Laboratories
- Bayer AG
- Glenmark Pharmaceutical
- Glaxosmithkline Plc.
Impacts of Covid-19 on the Market:
The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on ‘antifungal drugs market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2028, factoring the impact of COVID -19 Situation.
Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00003745/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876